E
Entropy Neurodynamics Ltd
OTC:TYPTF
Entropy Neurodynamics Ltd
OTC:TYPTF
Price:
0.012
USD
Market Closed
Market Cap:
$13.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Entropy Neurodynamics Ltd
OTC:TYPTF
|
AU |
|
Red Electrica Corporacion SA
MAD:RED
|
ES |
|
Burckhardt Compression Holding AG
SIX:BCHN
|
CH |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
P
|
Paladin Energy Ltd
F:PUR
|
AU |
|
C
|
Covista Inc
F:DVY
|
US |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
Nordic American Tanker Ltd
NYSE:NAT
|
BM |
Intrinsic Value
Not Available for TYPTF
There is not enough data to reliably calculate the intrinsic value for Entropy Neurodynamics Ltd.
Do our valuations actually work? See backtest results .
Alternatives to TYPTF
Fundamental Analysis
What Entropy Neurodynamics Does
Tryptamine Therapeutics Ltd is a drug-development company focused on medicines built around tryptamine compounds, the chemical family that includes well-known psychedelic molecules. Its work is aimed at turning those compounds into controlled pharmaceutical treatments, especially for mental health and other medical uses where standard drugs may not be enough.
- Headquarters
- Australia AU
- IPO date
- Dec 18, 2018
Financials
Efficiency
Earnings Waterfall
Entropy Neurodynamics Ltd
Entropy Neurodynamics Ltd
